Envestnet Asset Management Inc Bausch Health Companies Inc. Transaction History

Envestnet Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$7.06 - $23.63 $9,114 - $30,506	-1,291 Reduced 1.55%	82,037 $686,000
Q1 2022 May 04, 2022	SELL	$21.6 - $27.79 $144,806 - $186,304	-6,704 Reduced 7.45%	83,328 $1.9 Million
Q4 2021 Feb 04, 2022	SELL	$23.0 - $29.01 $141,036 - $177,889	-6,132 Reduced 6.38%	90,032 $2.49 Million
Q3 2021 Oct 07, 2021	SELL	$25.04 - $30.06 $32,602 - $39,138	-1,302 Reduced 1.34%	96,164 $2.68 Million
Q2 2021 Aug 04, 2021	BUY	$27.43 - $32.7 $114,026 - $135,933	4,157 Added 4.46%	97,466 $2.86 Million
Q1 2021 May 04, 2021	BUY	$21.37 - $34.38 $311,104 - $500,504	14,558 Added 18.49%	93,309 $2.96 Million
Q4 2020 Feb 02, 2021	BUY	$15.31 - $21.12 $140,744 - $194,156	9,193 Added 13.22%	78,751 $1.64 Million
Q3 2020 Oct 09, 2020	BUY	$14.88 - $20.13 $231,607 - $313,323	15,565 Added 28.83%	69,558 $1.08 Million
Q2 2020 Jul 08, 2020	BUY	$13.31 - $20.51 $260,010 - $400,662	19,535 Added 56.69%	53,993 $988,000
Q1 2020 Apr 23, 2020	SELL	$12.98 - $30.25 $74,738 - $174,179	-5,758 Reduced 14.32%	34,458 $534,000
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $759,680 - $1.28 Million	40,216 New	40,216 $1.2 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.